News

July 13, 2022
July 13, 2022

Ampersand Portfolio Company U.S. Alliance Pharma Acquires U.K.-based LGC’s Drug Development Solutions (DDS) Business

Do you like it?
Read more
June 23, 2022
June 23, 2022

Ampersand Capital Partners Invests in Sterling Medical Devices

Do you like it?
Read more
June 7, 2022
June 7, 2022

AnaBios Closes Financing with Ampersand Capital Partners

Do you like it?
Read more
June 2, 2022
June 2, 2022

Vernal Biosciences Raises $21 Million to Accelerate mRNA Manufacturing Growth

Do you like it?
Read more
May 17, 2022
May 17, 2022

Ampersand-backed Alliance Pharma to acquire LGC’s Drug Development Solutions Business (“DDS”) and welcomes KKR as joint shareholder

Do you like it?
Read more
April 21, 2022
April 21, 2022

American Laboratory Products Company Merges with GeneProof

Do you like it?
Read more
April 18, 2022
April 18, 2022

Ampersand Capital Partners Invests in Syft Technologies, Leading SIFT-MS Solutions Provider

Do you like it?
Read more
April 11, 2022
April 11, 2022

Alliance Pharma Appoints Patrick Bennett as Chief Executive Officer

Do you like it?
Read more
March 29, 2022
March 29, 2022

Ampersand Investment Opportunity: Syft Technologies

Do you like it?
Read more
March 17, 2022
March 17, 2022

Ampersand Invests Alongside KKR in Biosynth Carbosynth and Simultaneously Merges in vivitide

Do you like it?
Read more
123...17
Next page